| Dr Vedang J Bhavsar, MD | |
|
200 S Enota Dr Ne Ste 100, Gainesville, GA 30501-3466 | |
| (770) 534-2020 | |
| (770) 534-8025 |
| Full Name | Dr Vedang J Bhavsar |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 18 Years |
| Location | 200 S Enota Dr Ne Ste 100, Gainesville, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386872729 | NPI | - | NPPES |
| 1386872729 | Medicaid | MI | |
| P01368155 | Other | TN | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 82634 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeast Georgia Medical Center, Inc | Gainesville, GA | Hospital |
| Habersham County Medical Ctr | Demorest, GA | Hospital |
| Union General Hospital | Blairsville, GA | Hospital |
| Stephens County Hospital | Toccoa, GA | Hospital |
| Northside Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Georgia Heart Institute Llc | 4183848062 | 102 |
| Northeast Georgia Medical Center, Inc. | 7517953755 | 30 |
News Archive
Juventas Therapeutics, a privately held, clinical-stage regenerative medicine company announced it has started enrolling patients in a Phase I clinical trial for JVS-100 to evaluate safety and efficacy in the treatment of patients with Class III heart failure. JVS-100 encodes Stromal Cell-derived Factor-1 (SDF-1) and has been shown in pre-clinical studies to significantly increase cardiac function by promoting cell survival and increasing new blood vessel formation in the damaged organ.
Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has entered into a Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association.
The more specialized a hospital is in orthopedic surgical care, the better the outcomes appear to be for patients undergoing hip and knee replacement surgery, University of Iowa researchers report in a new study of Medicare patients.
On Wednesday, the WHO "urged medical aid agencies to stay in Haiti as long as possible while health care is rebuilt following last month's devastating earthquake," Agence France-Presse reports.
› Verified 2 days ago
| Entity Name | Northeast Georgia Medical Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720015993 PECOS PAC ID: 7517953755 Enrollment ID: O20040422000903 |
News Archive
Juventas Therapeutics, a privately held, clinical-stage regenerative medicine company announced it has started enrolling patients in a Phase I clinical trial for JVS-100 to evaluate safety and efficacy in the treatment of patients with Class III heart failure. JVS-100 encodes Stromal Cell-derived Factor-1 (SDF-1) and has been shown in pre-clinical studies to significantly increase cardiac function by promoting cell survival and increasing new blood vessel formation in the damaged organ.
Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has entered into a Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association.
The more specialized a hospital is in orthopedic surgical care, the better the outcomes appear to be for patients undergoing hip and knee replacement surgery, University of Iowa researchers report in a new study of Medicare patients.
On Wednesday, the WHO "urged medical aid agencies to stay in Haiti as long as possible while health care is rebuilt following last month's devastating earthquake," Agence France-Presse reports.
› Verified 2 days ago
| Entity Name | Georgia Heart Institute Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477976520 PECOS PAC ID: 4183848062 Enrollment ID: O20140616001425 |
News Archive
Juventas Therapeutics, a privately held, clinical-stage regenerative medicine company announced it has started enrolling patients in a Phase I clinical trial for JVS-100 to evaluate safety and efficacy in the treatment of patients with Class III heart failure. JVS-100 encodes Stromal Cell-derived Factor-1 (SDF-1) and has been shown in pre-clinical studies to significantly increase cardiac function by promoting cell survival and increasing new blood vessel formation in the damaged organ.
Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has entered into a Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association.
The more specialized a hospital is in orthopedic surgical care, the better the outcomes appear to be for patients undergoing hip and knee replacement surgery, University of Iowa researchers report in a new study of Medicare patients.
On Wednesday, the WHO "urged medical aid agencies to stay in Haiti as long as possible while health care is rebuilt following last month's devastating earthquake," Agence France-Presse reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vedang J Bhavsar, MD Po Box 742616, Atlanta, GA 30374-2616 Ph: (770) 219-8420 | Dr Vedang J Bhavsar, MD 200 S Enota Dr Ne Ste 100, Gainesville, GA 30501-3466 Ph: (770) 534-2020 |
News Archive
Juventas Therapeutics, a privately held, clinical-stage regenerative medicine company announced it has started enrolling patients in a Phase I clinical trial for JVS-100 to evaluate safety and efficacy in the treatment of patients with Class III heart failure. JVS-100 encodes Stromal Cell-derived Factor-1 (SDF-1) and has been shown in pre-clinical studies to significantly increase cardiac function by promoting cell survival and increasing new blood vessel formation in the damaged organ.
Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has entered into a Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association.
The more specialized a hospital is in orthopedic surgical care, the better the outcomes appear to be for patients undergoing hip and knee replacement surgery, University of Iowa researchers report in a new study of Medicare patients.
On Wednesday, the WHO "urged medical aid agencies to stay in Haiti as long as possible while health care is rebuilt following last month's devastating earthquake," Agence France-Presse reports.
› Verified 2 days ago
James D Jackson, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1285 Sims St, Gainesville, GA 30501 Phone: 770-219-8583 | |
Dr. Nitya S Chandra, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 S Enota Dr Ne Ste 100, Gainesville, GA 30501 Phone: 770-534-2020 Fax: 770-534-8025 | |
Dr. Lisa Armsrees Gillespie, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-219-8420 | |
Dr. Noelle Claudine Stanley, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1211 Sherwood Park Dr Ne Ste B, Gainesville, GA 30501 Phone: 770-219-9179 | |
Kedric Naylor, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-219-9000 Fax: 770-538-7872 | |
Dr. William Nathan Blake, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Ngpg Inpatient Medicine, Gainesville, GA 30501 Phone: 770-219-6000 Fax: 770-219-6021 | |
Roberto Manuel Villanueva, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1240 Jesse Jewell Pkwy Se, Suite 500, Gainesville, GA 30501 Phone: 770-536-9864 |